349 research outputs found

    Small molecules, big targets: drug discovery faces the protein-protein interaction challenge.

    Get PDF
    Protein-protein interactions (PPIs) are of pivotal importance in the regulation of biological systems and are consequently implicated in the development of disease states. Recent work has begun to show that, with the right tools, certain classes of PPI can yield to the efforts of medicinal chemists to develop inhibitors, and the first PPI inhibitors have reached clinical development. In this Review, we describe the research leading to these breakthroughs and highlight the existence of groups of structurally related PPIs within the PPI target class. For each of these groups, we use examples of successful discovery efforts to illustrate the research strategies that have proved most useful.JS, DES and ARB thank the Wellcome Trust for funding.This is the author accepted manuscript. The final version is available from Nature Publishing Group via http://dx.doi.org/10.1038/nrd.2016.2

    Using machine-learning-driven approaches to boost hot-spot's knowledge

    Get PDF
    Understanding protein–protein interactions (PPIs) is fundamental to describe and to characterize the formation of biomolecular assemblies, and to establish the energetic principles underlying biological networks. One key aspect of these interfaces is the existence and prevalence of hot-spots (HS) residues that, upon mutation to alanine, negatively impact the formation of such protein–protein complexes. HS have been widely considered in research, both in case studies and in a few large-scale predictive approaches. This review aims to present the current knowledge on PPIs, providing a detailed understanding of the microspecifications of the residues involved in those interactions and the characteristics of those defined as HS through a thorough assessment of related field-specific methodologies. We explore recent accurate artificial intelligence-based techniques, which are progressively replacing well-established classical energy-based methodologies. This article is categorized under: Data Science > Databases and Expert Systems Structure and Mechanism > Computational Biochemistry and Biophysics Molecular and Statistical Mechanics > Molecular Interactions

    Protein structure-based evaluation of missense variants: Resources, challenges and future directions.

    Get PDF
    We provide an overview of the methods that can be used for protein structure-based evaluation of missense variants. The algorithms can be broadly divided into those that calculate the difference in free energy (ΔΔG) between the wild type and variant structures and those that use structural features to predict the damaging effect of a variant without providing a ΔΔG. A wide range of machine learning approaches have been employed to develop those algorithms. We also discuss challenges and opportunities for variant interpretation in view of the recent breakthrough in three-dimensional structural modelling using deep learning

    Computational methodologies applied to Protein-Protein Interactions for molecular insights in Medicinal Chemistry

    Get PDF
    In living systems, proteins usually team up into \u201cmolecular machinery\u201d implementing several protein-to-protein physical contacts \u2013 or protein-protein interactions (PPIs) \u2013 to exert biological effects at both cellular and systems levels. Deregulations of protein-protein contacts have been associated with a huge number of diseases in a wide range of medical areas, such as oncology, cancer immunotherapy, infectious diseases, neurological disorders, heart failure, inflammation and oxidative stress. PPIs are very complex and usually characterised by specific shape, size and complementarity. The protein interfaces are generally large, broad and shallow, and frequently protein-protein contacts are established between non-continuous epitopes, that conversely are dislocated across the protein interfaces. For this reason, in the past two decades, PPIs were thought to be \u201cundruggable\u201d targets by the scientific research community with scarce or no chance of success. However, in recent years the Medicinal Chemistry frontiers have been changing and PPIs have gained popularity amongst the research groups due to their key roles in such a huge number of diseases. Until recently, PPIs were determined by experimental evidence through techniques specifically developed to target a small group of interactions. However, these methods present several limitations in terms of high costs and labour- and time-wasting. Nowadays, a large number of computational methods have been successfully applied to evaluate, validate, and deeply analyse the experimentally determined protein interactomes. In this context, a high number of computational tools and techniques have been developed, such as methods designed to construct interaction databases, quantum mechanics and molecular mechanics (QM/MM) to study the electronic properties, simulate chemical reactions, and calculate spectra, and all-atom molecular dynamics simulations to simulate temporal and spatial scales of inter- and intramolecular interactions. These techniques have allowed to explore PPI networks and predict the related functional features. In this PhD work, an extensive use of computational techniques has been reported as valuable tool to explore protein-protein interfaces, identify their hot spot residues, select small molecules and design peptides with the aim of inhibiting six different studied PPIs. Indeed, in this thesis, a success story of in silico approaches to PPI study has been described, where MD simulations, docking and pharmacophore screenings led to the identification of a set of PPI modulators. Among these, two molecules, RIM430 and RIM442, registered good inhibitory activity with IC50 values even within the nanomolar range against the interaction between MUC1 and CIN85 proteins in cancer disease. Furthermore, computational alanine scanning, all-atom molecular dynamics simulations, docking and pharmacophore screening were exploited to (1) rationally predict three potential interaction models of NLRP3PYD-ASCPYD complex involved in inflammatory and autoimmune diseases; (2) identify a potentially druggable region on the surface of SARS-CoV-2 Spike protein interface and select putative inhibitors of the interaction between Spike protein and the host ACE2 receptor against COVID-19 (CoronaVIrus Disease 2019); (3) investigate intramolecular modifications as a consequence of a point mutation on C3b protein (R102G) associated with the age-related macular degeneration (AMD) disease; (4) design non-standard peptides to inhibit transcriptional events associated with HOX-PBX complex involved in cancer diseases; and (5) to optimise a patented peptide sequence by designing helix-shaped peptides embedded with the hydrogen bond surrogate approach to tackle cocaine abuse relapses associated with Ras-RasGRF1 interaction. Although all the herein exploited techniques are based on predictive calculations and need experimental evidence to confirm the findings, the results and molecular insights retrieved and collected show the potential of the computer-aided drug design applied to the Medicinal Chemistry, guaranteeing labour- and time-saving to the research groups. On the other hand, computing ability, improved algorithms and fast-growing data sets are rapidly fostering advances in multiscale molecular modelling, providing a powerful emerging paradigm for drug discovery. It means that more and more research efforts will be done to invest in novel and more precise computational techniques and fine-tune the currently employed methodologies

    Computational Methods for Predicting Protein-protein Interactions and Binding Sites

    Get PDF
    Proteins are essential to organisms and participate in virtually every process within cells. Quite often, they keep the cells functioning by interacting with other proteins. This process is called protein-protein interaction (PPI). The bonding amino acid residues during the process of protein-protein interactions are called PPI binding sites. Identifying PPIs and PPI binding sites are fundamental problems in system biology. Experimental methods for solving these two problems are slow and expensive. Therefore, great efforts are being made towards increasing the performance of computational methods. We present DELPHI, a deep learning based program for PPI site prediction and SPRINT, an algorithmic based program for PPI prediction. Both programs have been compared to the state-of-the-art programs on several datasets. Both DELPHI and SPRINT are more accurate than the competing method. SPRINT is also orders of magnitudes faster while using very little memory. The dataset and source code for both DELPHI and SPRINT are publicly available at: github.com/lucian-ilie and and www.csd.uwo.ca/~ilie/software.htm

    Structural Investigation of Binding Events in Proteins

    Full text link
    Understanding the biophysical properties that describe protein binding events has allowed for the advancement of drug discovery through structure-based drug design and in silico methodology. The accuracy of these in silico methods depends entirely on the parameters that we determine for them. Many of these parameters are derived from the structural information we have obtained as a community and therein resides the importance of integrity of the quality of this structural data. First, the curation and contents of the Binding MOAD database are extensively described. This database serves as a repository of 25,759 high-quality, ligand-bound X-ray protein crystal structures complemented by 9138 hand-curated binding affinity data for as many of those ligands as appropriate. The newly implemented extended binding site feature is presented, establishing more robust definitions of ligand binding sites than those provided by other databases. Finally, the contents of Binding MOAD are compared to similar databases, establishing the value of our dataset and which purposes it best serves. Second, a robust dataset of 305 unique protein sequences with at least two ligand-bound and two ligand-free structures for each unique protein is cultivated from Binding MOAD and the PDB. Protein flexibility is assessed using C-alpha RMSD for backbone motion and chi-1 angles to quantify side-chain motions. We establish that there is no statistically significant difference between the available conformational space for the backbones or the side chains of unbound proteins when compared to their bound structures. Examining the change in occupied conformational space upon ligand binding reveals a statistically significant increase in backbone conformational space of miniscule magnitude, but a significant increase of side-chain conformational space. To quantify the conformational space available to the side chains, flexibility profiles are established for each amino acid. We found no correlation between backbone and side-chain flexibility. Parallels are then made to common practices in flexible docking techniques. Six binding-site prediction algorithms are then benchmarked on a derivation of the previously established dataset of 305 proteins. We assessed the performance of ligand-bound vs ligand-free structures with these methods and concluded that five of the six methods showed no preference for either structure type. The remaining method, Fpocket, showed decreased performance for ligand-free structures. There was a staggering amount of inconsistency in performance with the methods; different structures of the exact same protein could achieve wildly different rates of success with the same method. The performance of individual structures for all six methods indicated that success and failure rates were seemingly random. Finally, we establish no correlation between the performance of the same structures with different methods, or the performance of the structures with structure resolution, Cruickshank DPI, or number of unresolved residues in their binding sites. Last, we examine the chemical and physical properties of protein-protein interactions (PPIs) with regard to their geometric location in the interface. First, we found that the relative elevation changes of the protein interface landscapes demonstrate that these interfaces are not as flat as previously described. Second, the hollows of druggable PPI interfaces are more sharply shaped and nonpolar in nature, and the protrusions of these druggable PPI interfaces are very polar in character. Last, no correlations exist between the binding affinity describing the subunits of a PPI and other physical and chemical parameters that we measured.PHDMedicinal ChemistryUniversity of Michigan, Horace H. Rackham School of Graduate Studieshttps://deepblue.lib.umich.edu/bitstream/2027.42/145943/1/jordanjc_1.pd

    From condition-specific interactions towards the differential complexome of proteins

    Get PDF
    While capturing the transcriptomic state of a cell is a comparably simple effort with modern sequencing techniques, mapping protein interactomes and complexomes in a sample-specific manner is currently not feasible on a large scale. To understand crucial biological processes, however, knowledge on the physical interplay between proteins can be more interesting than just their mere expression. In this thesis, we present and demonstrate four software tools that unlock the cellular wiring in a condition-specific manner and promise a deeper understanding of what happens upon cell fate transitions. PPIXpress allows to exploit the abundance of existing expression data to generate specific interactomes, which can even consider alternative splicing events when protein isoforms can be related to the presence of causative protein domain interactions of an underlying model. As an addition to this work, we developed the convenient differential analysis tool PPICompare to determine rewiring events and their causes within the inferred interaction networks between grouped samples. Furthermore, we present a new implementation of the combinatorial protein complex prediction algorithm DACO that features a significantly reduced runtime. This improvement facilitates an application of the method for a large number of samples and the resulting sample-specific complexes can ultimately be assessed quantitatively with our novel differential protein complex analysis tool CompleXChange.Das Transkriptom einer Zelle ist mit modernen Sequenzierungstechniken vergleichsweise einfach zu erfassen. Die Ermittlung von Proteininteraktionen und -komplexen wiederum ist in großem Maßstab derzeit nicht möglich. Um wichtige biologische Prozesse zu verstehen, kann das Zusammenspiel von Proteinen jedoch erheblich interessanter sein als deren reine Expression. In dieser Arbeit stellen wir vier Software-Tools vor, die es ermöglichen solche Interaktionen zustandsbezogen zu betrachten und damit ein tieferes Verständnis darüber versprechen, was in der Zelle bei Veränderungen passiert. PPIXpress ermöglicht es vorhandene Expressionsdaten zu nutzen, um die aktiven Interaktionen in einem biologischen Kontext zu ermitteln. Wenn Proteinvarianten mit Interaktionen von Proteindomänen in Verbindung gebracht werden können, kann hierbei sogar alternatives Spleißen berücksichtigen werden. Als Ergänzung dazu haben wir das komfortable Differenzialanalyse-Tool PPICompare entwickelt, welches Veränderungen des Interaktoms und deren Ursachen zwischen gruppierten Proben bestimmen kann. Darüber hinaus stellen wir eine neue Implementierung des Proteinkomplex-Vorhersagealgorithmus DACO vor, die eine deutlich reduzierte Laufzeit aufweist. Diese Verbesserung ermöglicht die Anwendung der Methode auf eine große Anzahl von Proben. Die damit bestimmten probenspezifischen Komplexe können schließlich mit unserem neuartigen Differenzialanalyse-Tool CompleXChange quantitativ bewertet werden
    corecore